SlideShare a Scribd company logo
Complications of Peritoneal Dialysis Abhijit Kontamwar,MD Renal Consultants, Inc  Clinical Assistant Professor of Internal Medicine at NEOUCOM (Northeastern Ohio Universities Colleges of Medicine and Pharmacy).
Complications  ,[object Object],[object Object]
Case  ,[object Object],[object Object],[object Object],[object Object]
Infectious complications ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Causes of transfer to HD among PD patients Mujais et al; Kidney Int Suppl 2006; 70: S21-36
Hospitalization rates for access related infections Chavers et al, J Am Soc Nephrol 18: 952 – 959, 2007
Peritonitis  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
How does bacteria gain entry into peritoneal cavity? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Pathophysiology  ,[object Object],[object Object],[object Object],[object Object],[object Object]
Flush before fill ,[object Object],[object Object],[object Object],[object Object]
Diagnosis  ,[object Object],[object Object],[object Object],[object Object]
Specimen collection and processing  ,[object Object],[object Object],[object Object],[object Object],[object Object]
Microbiology  Friedrich et al, Kidney Int, Oct 1992; 42: 967-974
Microbiology Mujais, S. Microbiology and outcomes of peritonitis in North America. Kidney Int 2006; 70:S55
Gram +ive organisms ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Gram –ve organisms ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Treatment  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Treatment  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Empiric Therapy Initiate empiric therapy Simultaneous gram +ve and gram –ve coverage For prevention of fibrin occlusion  heparin 500 U/L can be used Gram +ve coverage: 1 st  generation cephalosporin  or vancomycin Gram –ve coverage: 3 rd  generation cephalosporin  or aminoglycoside
Empiric therapy ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Mode of antibiotic administration ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Staph. aureus peritonitis Staph. Aureus on culture D/c gram –ve coverage, cont. gram +ve  coverage for 3 weeks If MRSA change to Vancomycin and rifampin can  be added (600 mg/day for 1 week) If clinical improvement continue  for 3 weeks If no clinical improvement  reculture and revaluate for exit-site or tunnel Infection or intra-abd abscess If peritonitis with exit-site or tunnel  Infection – remove catheter Allow 2 weeks rest period before reinitiating PD If no improvement in 5 days on appropriate  antibiotics, remove catheter
Enterococcus/Streptococcus peritonitis Enterococcus/Strep on culture D/c empiric coverage Start continuous Ampicillin 125 mg/L each bag Consider adding aminoglycoside for enterococcus If ampicillin resistant, start vanco; If VRE consider quinupristin/dalfopristin or linezolid Clinical improvement; treat for  2 weeks – strep 3 weeks - enterococcus No improvement, reculture  and evaluate for exit-site or tunnel infection Peritonitis with exit or tunnel infection Consider catheter removal Treat for 3 weeks In no improvement by 5 days, remove catheter
Pseudomonas peritonitis Pseudomonas on culture W/o exit-site/tunnel infection With exit-site/tunnel infection Remove catheter Use 2 abx with different mechanism Oral quinolone, cephalosporin, piperacillin based on sensitivities If clinical improvement Treat for 3 weeks If no improvement reculture and evaluate If no improvement by 5 days on  appropriate abx, remove catheter
Gram negative organism peritonitis Single gram –ve  organism on culture E. coli, klebsiella  or proteus Stenotrophomonas  3 rd  generation cephalosporin: ceftazidime or cefepime Two drugs with different mechanisms based on sensitivity pattern Duration of therapy: 3 weeks Duration of therapy: 3-4 weeks If no clinical improvement by 5 days, remove catheter
Polymicrobial peritonitis Polymicrobial peritonitis Multiple gram –ve organisms Multiple gram +ve organisms   Change to metronidazole In conjunction with ampicillin, Ceftazidime or aminoglycoside Surgical evaluation Laprotomy for suspected intra-abd pathology/abscess with catheter removal Continue therapy based on sensitivities W/o catheter infection, treat for 3 weeks With catheter infection, remove catheter
Culture negative peritonitis Culture negative peritonitis 24-48 hours Continue initial therapy If culture negative for 72 hours Repeat cell count and diff Infection resolving, pt improving Infection not resolving Cont initial therapy for 2 weeks, But D/c aminoglycoside if used initially Special culture techniques for Mycobacteria or legionella Culture positive Culture negative Adjust therapy as per sensitivity patterns If no improvement in 5 days, Consider catheter removal
Other causes of peritonitis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Antibiotic dosing recommendations for CAPD LD: loading dose in mg, MD: maintenance dose in mg Antibiotic Intermittent Continuous Gentamicin  0.6 mg/kg LD 8, MD 4 Amikacin 2 mg/kg LD 25, MD 12 Cefazolin 15 mg/kg LD 500, MD 125 Cefepime 1 gm LD 500, MD 125 Cephalothin 15 mg/kg LD 500, MD 125 Ceftazidime 1 – 1.5 gm LD 500, MD 125 Ciprofloxacin  No data LD 50, MD 25 Vancomycin 15-30 mg/kg every 5-7 days LD 1000, MD 25 Aztreonam No data LD 1000, MD 250 Amphotericin NA 1.5 Imipenem/cilistatin 1 gm bid LD 500, MD 200
Intermittent dosing of antibiotics in APD ,[object Object],[object Object],[object Object],[object Object]
Catheter removal in peritonitis patients ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Other causes of cloudy effluent ,[object Object],[object Object],[object Object]
Eosinophilic peritonitis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
PD catheter removal after transplant ,[object Object],[object Object],[object Object]
Case  ,[object Object],[object Object],[object Object],[object Object],[object Object]
Other causes of abdominal pain in PD patients ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Exit-site/Tunnel infection ,[object Object],[object Object],[object Object],[object Object]
 
Treatment of exit-site/tunnel infection Purulent discharge from exit-site Do culture/gram stain Gram +ve organism Gram –ve organism 1 st  generation Cephalosporin PO PO Quinolones If slow improvement or severe Cases add Rifampin 600mg/day If Pseudomonas and  no improvement  add 2 nd   anti-pseudomonal; ceftazidime IP Infection resolving; cont  treatment for 2 weeks Infection resolving; cont  treatment for 2 weeks Infection unresolved in 3-4 weeks; consider catheter revision/removal Infection unresolved in 3-4 weeks; consider catheter revision/removal
[object Object]
Non-infectious complications Non infectious  complications Catheter related Catheter unrelated ,[object Object],[object Object],[object Object],[object Object],[object Object],GERD Hemoperitoneum Back/abdominal pain UF failure Abdominal wall herniation Peritoneal sclerosis Pleural effusion Metabolic
Case  ,[object Object],[object Object],[object Object],[object Object],[object Object]
 
Outflow failure ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Diagnosis  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Treatment  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Treatment ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Case  ,[object Object]
Pericatheter leakage ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Pericatheter leakage ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Pericatheter leakage ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Case  ,[object Object],[object Object],[object Object],[object Object]
 
Pleural effusion ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Pleural effusion ,[object Object],[object Object],[object Object],[object Object],[object Object]
Pleural effusion ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Pleural effusion ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Catheter cuff extrusion ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Intestinal perforation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Bleeding exit-site ,[object Object],[object Object],[object Object],[object Object],[object Object]
Case  ,[object Object]
Hemoperitoneum  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],During training, warn females in advance!
Hemoperitoneum ,[object Object],[object Object],[object Object],[object Object]
Case  ,[object Object],[object Object],[object Object]
GERD and delayed gastric emptying ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Case  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Back pain ,[object Object],[object Object],[object Object],[object Object],[object Object]
Case  ,[object Object],[object Object],[object Object]
Peritoneal Scintigram
 
Hernia  ,[object Object],[object Object],[object Object],[object Object],[object Object]
Dialysate infusion pain ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Metabolic  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Encapsulating peritoneal sclerosis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
EPS: Diagnosis  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
 
EPS: Treatment  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

More Related Content

What's hot

Adequacy of haemodialysis
Adequacy of haemodialysisAdequacy of haemodialysis
Adequacy of haemodialysis
Dr Narinder Sharma
 
Complications of hemodialysis
Complications of hemodialysisComplications of hemodialysis
Complications of hemodialysisReynel Dan
 
Dialysis various modalities and indices used
Dialysis various modalities and indices usedDialysis various modalities and indices used
Dialysis various modalities and indices usedAbhay Mange
 
Adequacy of Hemodialysis
Adequacy of HemodialysisAdequacy of Hemodialysis
Adequacy of Hemodialysis
MNDU net
 
Acute peritoneal dialysis prescription
Acute peritoneal dialysis prescriptionAcute peritoneal dialysis prescription
Acute peritoneal dialysis prescription
IPMS- KMU KPK PAKISTAN
 
Principles of-hemodialysis
Principles of-hemodialysisPrinciples of-hemodialysis
Principles of-hemodialysis
FarragBahbah
 
Hemodialysis complications
Hemodialysis complications Hemodialysis complications
Hemodialysis complications
FarragBahbah
 
Peritonitis, exit site care, catheter related infection
Peritonitis, exit site care, catheter related infectionPeritonitis, exit site care, catheter related infection
Peritonitis, exit site care, catheter related infection
Muhammad Mohsin Riaz
 
Hemodialysis in children
Hemodialysis in childrenHemodialysis in children
Hemodialysis in children
FarragBahbah
 
Dialysis prescription 2
Dialysis prescription 2Dialysis prescription 2
Dialysis prescription 2
Chioma Iheme
 
Hemodialysis anticoagulation
Hemodialysis anticoagulationHemodialysis anticoagulation
Hemodialysis anticoagulation
Abdullah Ansari
 
Evaluation of peritoneal membrane
Evaluation of peritoneal membraneEvaluation of peritoneal membrane
Evaluation of peritoneal membrane
Muhammad Mohsin Riaz
 
Renal replacement therapy
Renal replacement therapyRenal replacement therapy
Renal replacement therapy
nagarjunanri
 
Hd Prescription
Hd PrescriptionHd Prescription
Hd Prescription
MNDU net
 
Pd aki 2019
Pd aki 2019Pd aki 2019
Pd aki 2019
FarragBahbah
 
Hemodialysis in-children-2
Hemodialysis in-children-2Hemodialysis in-children-2
Hemodialysis in-children-2
FarragBahbah
 
Vascular access
Vascular accessVascular access
Vascular access
FarragBahbah
 
Peritoneal dialysis catheter
Peritoneal dialysis catheterPeritoneal dialysis catheter
Peritoneal dialysis catheter
IPMS- KMU KPK PAKISTAN
 

What's hot (20)

Adequacy of haemodialysis
Adequacy of haemodialysisAdequacy of haemodialysis
Adequacy of haemodialysis
 
Complications of hemodialysis
Complications of hemodialysisComplications of hemodialysis
Complications of hemodialysis
 
Dialysis various modalities and indices used
Dialysis various modalities and indices usedDialysis various modalities and indices used
Dialysis various modalities and indices used
 
Adequacy of Hemodialysis
Adequacy of HemodialysisAdequacy of Hemodialysis
Adequacy of Hemodialysis
 
Acute peritoneal dialysis prescription
Acute peritoneal dialysis prescriptionAcute peritoneal dialysis prescription
Acute peritoneal dialysis prescription
 
Principles of-hemodialysis
Principles of-hemodialysisPrinciples of-hemodialysis
Principles of-hemodialysis
 
Hemodialysis complications
Hemodialysis complications Hemodialysis complications
Hemodialysis complications
 
Peritonitis, exit site care, catheter related infection
Peritonitis, exit site care, catheter related infectionPeritonitis, exit site care, catheter related infection
Peritonitis, exit site care, catheter related infection
 
Hemodialysis in children
Hemodialysis in childrenHemodialysis in children
Hemodialysis in children
 
Dialysis prescription 2
Dialysis prescription 2Dialysis prescription 2
Dialysis prescription 2
 
Hemodialysis anticoagulation
Hemodialysis anticoagulationHemodialysis anticoagulation
Hemodialysis anticoagulation
 
PD prescription
PD prescriptionPD prescription
PD prescription
 
Evaluation of peritoneal membrane
Evaluation of peritoneal membraneEvaluation of peritoneal membrane
Evaluation of peritoneal membrane
 
CRRT
CRRTCRRT
CRRT
 
Renal replacement therapy
Renal replacement therapyRenal replacement therapy
Renal replacement therapy
 
Hd Prescription
Hd PrescriptionHd Prescription
Hd Prescription
 
Pd aki 2019
Pd aki 2019Pd aki 2019
Pd aki 2019
 
Hemodialysis in-children-2
Hemodialysis in-children-2Hemodialysis in-children-2
Hemodialysis in-children-2
 
Vascular access
Vascular accessVascular access
Vascular access
 
Peritoneal dialysis catheter
Peritoneal dialysis catheterPeritoneal dialysis catheter
Peritoneal dialysis catheter
 

Similar to Complications of peritoneal dialysis

Infective Complications In Pd
Infective Complications In PdInfective Complications In Pd
Infective Complications In Pd
edwinchowyw
 
Febrile neutropaenia
Febrile neutropaeniaFebrile neutropaenia
Febrile neutropaenia
Saqi Md. Abdul Baqi
 
Complication peritoneal dailysis traning
Complication peritoneal dailysis traningComplication peritoneal dailysis traning
Complication peritoneal dailysis traning
Dr.Jose Luis Rodriguez Lopez
 
Peritonitis
PeritonitisPeritonitis
Febrile neutropenia ankur
Febrile neutropenia ankurFebrile neutropenia ankur
Febrile neutropenia ankur
Ankur Varshney
 
clostridium Diarrhea
clostridium Diarrheaclostridium Diarrhea
clostridium Diarrhea
Vivian Barrera
 
Uti policy-lec
Uti policy-lecUti policy-lec
Uti policy-lec
FarragBahbah
 
clostridium diarrhea
clostridium diarrheaclostridium diarrhea
clostridium diarrhea
Vivian Barrera
 
Capd peritonitis mortalty
Capd peritonitis mortaltyCapd peritonitis mortalty
Capd peritonitis mortaltyxinnirah
 
Crohns Disease of the Anus
Crohns Disease of the AnusCrohns Disease of the Anus
Crohns Disease of the Anus
jimmystrein
 
MANAGEMENT OF INFECTIONS IN
MANAGEMENT OF INFECTIONS INMANAGEMENT OF INFECTIONS IN
MANAGEMENT OF INFECTIONS INNeurologyKota
 
Case presentation Urosepsis
Case presentation UrosepsisCase presentation Urosepsis
Case presentation Urosepsis
tbf413
 
seminar on urinary tract infection
seminar on urinary tract infectionseminar on urinary tract infection
seminar on urinary tract infection
Dr. Habibur Rahim
 
Ascites related complications final
Ascites related complications finalAscites related complications final
Ascites related complications final
Amith Kumar
 
complication of peritoneal dialysis
complication of peritoneal dialysiscomplication of peritoneal dialysis
complication of peritoneal dialysis
Pediatric Nephrology
 
Antibiotic associated diarrhea & Clostridium difficile infection
Antibiotic associated diarrhea & Clostridium difficile infectionAntibiotic associated diarrhea & Clostridium difficile infection
Antibiotic associated diarrhea & Clostridium difficile infection
Santosh Narayankar
 
Diagnosis and management of PID
Diagnosis and management of PIDDiagnosis and management of PID
Diagnosis and management of PID
Aswathi Raveendran U.V
 
Relapsing coagulase negative staphylococcus peritonitis
Relapsing coagulase negative staphylococcus peritonitis Relapsing coagulase negative staphylococcus peritonitis
Relapsing coagulase negative staphylococcus peritonitis
Ahmed Mostafa Taha Borham
 
spontaneous bacterial peritonitis.pptx
spontaneous bacterial peritonitis.pptxspontaneous bacterial peritonitis.pptx
spontaneous bacterial peritonitis.pptx
TanvirIslam94
 
GI10. Peritonitis 202bbbbbbbbbbbb1 (2).pptx
GI10. Peritonitis 202bbbbbbbbbbbb1 (2).pptxGI10. Peritonitis 202bbbbbbbbbbbb1 (2).pptx
GI10. Peritonitis 202bbbbbbbbbbbb1 (2).pptx
mekuriatadesse
 

Similar to Complications of peritoneal dialysis (20)

Infective Complications In Pd
Infective Complications In PdInfective Complications In Pd
Infective Complications In Pd
 
Febrile neutropaenia
Febrile neutropaeniaFebrile neutropaenia
Febrile neutropaenia
 
Complication peritoneal dailysis traning
Complication peritoneal dailysis traningComplication peritoneal dailysis traning
Complication peritoneal dailysis traning
 
Peritonitis
PeritonitisPeritonitis
Peritonitis
 
Febrile neutropenia ankur
Febrile neutropenia ankurFebrile neutropenia ankur
Febrile neutropenia ankur
 
clostridium Diarrhea
clostridium Diarrheaclostridium Diarrhea
clostridium Diarrhea
 
Uti policy-lec
Uti policy-lecUti policy-lec
Uti policy-lec
 
clostridium diarrhea
clostridium diarrheaclostridium diarrhea
clostridium diarrhea
 
Capd peritonitis mortalty
Capd peritonitis mortaltyCapd peritonitis mortalty
Capd peritonitis mortalty
 
Crohns Disease of the Anus
Crohns Disease of the AnusCrohns Disease of the Anus
Crohns Disease of the Anus
 
MANAGEMENT OF INFECTIONS IN
MANAGEMENT OF INFECTIONS INMANAGEMENT OF INFECTIONS IN
MANAGEMENT OF INFECTIONS IN
 
Case presentation Urosepsis
Case presentation UrosepsisCase presentation Urosepsis
Case presentation Urosepsis
 
seminar on urinary tract infection
seminar on urinary tract infectionseminar on urinary tract infection
seminar on urinary tract infection
 
Ascites related complications final
Ascites related complications finalAscites related complications final
Ascites related complications final
 
complication of peritoneal dialysis
complication of peritoneal dialysiscomplication of peritoneal dialysis
complication of peritoneal dialysis
 
Antibiotic associated diarrhea & Clostridium difficile infection
Antibiotic associated diarrhea & Clostridium difficile infectionAntibiotic associated diarrhea & Clostridium difficile infection
Antibiotic associated diarrhea & Clostridium difficile infection
 
Diagnosis and management of PID
Diagnosis and management of PIDDiagnosis and management of PID
Diagnosis and management of PID
 
Relapsing coagulase negative staphylococcus peritonitis
Relapsing coagulase negative staphylococcus peritonitis Relapsing coagulase negative staphylococcus peritonitis
Relapsing coagulase negative staphylococcus peritonitis
 
spontaneous bacterial peritonitis.pptx
spontaneous bacterial peritonitis.pptxspontaneous bacterial peritonitis.pptx
spontaneous bacterial peritonitis.pptx
 
GI10. Peritonitis 202bbbbbbbbbbbb1 (2).pptx
GI10. Peritonitis 202bbbbbbbbbbbb1 (2).pptxGI10. Peritonitis 202bbbbbbbbbbbb1 (2).pptx
GI10. Peritonitis 202bbbbbbbbbbbb1 (2).pptx
 

More from Hofstra Northwell School of Medicine

Amacing
AmacingAmacing
Acute Kidney Injury in the Cardiac Surgery Patient
Acute Kidney Injury in the Cardiac Surgery PatientAcute Kidney Injury in the Cardiac Surgery Patient
Acute Kidney Injury in the Cardiac Surgery Patient
Hofstra Northwell School of Medicine
 
Primary hyperoxaluria and the Kidney
Primary hyperoxaluria and the KidneyPrimary hyperoxaluria and the Kidney
Primary hyperoxaluria and the Kidney
Hofstra Northwell School of Medicine
 
Obesity paradox
Obesity paradoxObesity paradox
Proteinuria, A medical student prespective
Proteinuria, A medical student prespectiveProteinuria, A medical student prespective
Proteinuria, A medical student prespective
Hofstra Northwell School of Medicine
 
Journal Club:SuPAR and FSGS
Journal Club:SuPAR and FSGSJournal Club:SuPAR and FSGS
Journal Club:SuPAR and FSGS
Hofstra Northwell School of Medicine
 
Journal Club: Daily Corticosteroids Reduce Infection-associated Relapses in F...
Journal Club: Daily Corticosteroids Reduce Infection-associated Relapses in F...Journal Club: Daily Corticosteroids Reduce Infection-associated Relapses in F...
Journal Club: Daily Corticosteroids Reduce Infection-associated Relapses in F...
Hofstra Northwell School of Medicine
 
Journal Club: Residual renal function
Journal Club: Residual renal functionJournal Club: Residual renal function
Journal Club: Residual renal function
Hofstra Northwell School of Medicine
 
Cystic disease of the kidney
Cystic disease of the kidneyCystic disease of the kidney
Cystic disease of the kidney
Hofstra Northwell School of Medicine
 
Viruses and the kidney
Viruses and the kidneyViruses and the kidney
Viruses and the kidney
Hofstra Northwell School of Medicine
 
Hematuria post transplant
Hematuria post transplantHematuria post transplant
Hematuria post transplant
Hofstra Northwell School of Medicine
 

More from Hofstra Northwell School of Medicine (20)

Amacing
AmacingAmacing
Amacing
 
Amacing
AmacingAmacing
Amacing
 
TA-TMA
TA-TMATA-TMA
TA-TMA
 
HSCT-TMA
HSCT-TMAHSCT-TMA
HSCT-TMA
 
TA-TMA
TA-TMATA-TMA
TA-TMA
 
TA-TMA
TA-TMATA-TMA
TA-TMA
 
HSCT-TMA
HSCT-TMAHSCT-TMA
HSCT-TMA
 
Acute Kidney Injury in the Cardiac Surgery Patient
Acute Kidney Injury in the Cardiac Surgery PatientAcute Kidney Injury in the Cardiac Surgery Patient
Acute Kidney Injury in the Cardiac Surgery Patient
 
Aki cticu final
Aki cticu finalAki cticu final
Aki cticu final
 
Primary hyperoxaluria and the Kidney
Primary hyperoxaluria and the KidneyPrimary hyperoxaluria and the Kidney
Primary hyperoxaluria and the Kidney
 
Obesity paradox
Obesity paradoxObesity paradox
Obesity paradox
 
Journal Club:Stem cells and Kidney Transplantation
Journal Club:Stem cells and Kidney TransplantationJournal Club:Stem cells and Kidney Transplantation
Journal Club:Stem cells and Kidney Transplantation
 
Proteinuria, A medical student prespective
Proteinuria, A medical student prespectiveProteinuria, A medical student prespective
Proteinuria, A medical student prespective
 
Journal Club:SuPAR and FSGS
Journal Club:SuPAR and FSGSJournal Club:SuPAR and FSGS
Journal Club:SuPAR and FSGS
 
FGF-23 and Mortality in Dialysis patients- Journal Club
FGF-23 and Mortality in Dialysis patients- Journal ClubFGF-23 and Mortality in Dialysis patients- Journal Club
FGF-23 and Mortality in Dialysis patients- Journal Club
 
Journal Club: Daily Corticosteroids Reduce Infection-associated Relapses in F...
Journal Club: Daily Corticosteroids Reduce Infection-associated Relapses in F...Journal Club: Daily Corticosteroids Reduce Infection-associated Relapses in F...
Journal Club: Daily Corticosteroids Reduce Infection-associated Relapses in F...
 
Journal Club: Residual renal function
Journal Club: Residual renal functionJournal Club: Residual renal function
Journal Club: Residual renal function
 
Cystic disease of the kidney
Cystic disease of the kidneyCystic disease of the kidney
Cystic disease of the kidney
 
Viruses and the kidney
Viruses and the kidneyViruses and the kidney
Viruses and the kidney
 
Hematuria post transplant
Hematuria post transplantHematuria post transplant
Hematuria post transplant
 

Recently uploaded

Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
Peter Windle
 
Marketing internship report file for MBA
Marketing internship report file for MBAMarketing internship report file for MBA
Marketing internship report file for MBA
gb193092
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
Peter Windle
 
Normal Labour/ Stages of Labour/ Mechanism of Labour
Normal Labour/ Stages of Labour/ Mechanism of LabourNormal Labour/ Stages of Labour/ Mechanism of Labour
Normal Labour/ Stages of Labour/ Mechanism of Labour
Wasim Ak
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
DhatriParmar
 
Chapter -12, Antibiotics (One Page Notes).pdf
Chapter -12, Antibiotics (One Page Notes).pdfChapter -12, Antibiotics (One Page Notes).pdf
Chapter -12, Antibiotics (One Page Notes).pdf
Kartik Tiwari
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Dr. Vinod Kumar Kanvaria
 
Multithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race conditionMultithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race condition
Mohammed Sikander
 
Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School DistrictPride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
David Douglas School District
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
EduSkills OECD
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 

Recently uploaded (20)

Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
 
Marketing internship report file for MBA
Marketing internship report file for MBAMarketing internship report file for MBA
Marketing internship report file for MBA
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
 
Normal Labour/ Stages of Labour/ Mechanism of Labour
Normal Labour/ Stages of Labour/ Mechanism of LabourNormal Labour/ Stages of Labour/ Mechanism of Labour
Normal Labour/ Stages of Labour/ Mechanism of Labour
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
 
Chapter -12, Antibiotics (One Page Notes).pdf
Chapter -12, Antibiotics (One Page Notes).pdfChapter -12, Antibiotics (One Page Notes).pdf
Chapter -12, Antibiotics (One Page Notes).pdf
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
 
Multithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race conditionMultithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race condition
 
Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School DistrictPride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 

Complications of peritoneal dialysis

  • 1. Complications of Peritoneal Dialysis Abhijit Kontamwar,MD Renal Consultants, Inc Clinical Assistant Professor of Internal Medicine at NEOUCOM (Northeastern Ohio Universities Colleges of Medicine and Pharmacy).
  • 2.
  • 3.
  • 4.
  • 5. Causes of transfer to HD among PD patients Mujais et al; Kidney Int Suppl 2006; 70: S21-36
  • 6. Hospitalization rates for access related infections Chavers et al, J Am Soc Nephrol 18: 952 – 959, 2007
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13. Microbiology Friedrich et al, Kidney Int, Oct 1992; 42: 967-974
  • 14. Microbiology Mujais, S. Microbiology and outcomes of peritonitis in North America. Kidney Int 2006; 70:S55
  • 15.
  • 16.
  • 17.
  • 18.
  • 19. Empiric Therapy Initiate empiric therapy Simultaneous gram +ve and gram –ve coverage For prevention of fibrin occlusion heparin 500 U/L can be used Gram +ve coverage: 1 st generation cephalosporin or vancomycin Gram –ve coverage: 3 rd generation cephalosporin or aminoglycoside
  • 20.
  • 21.
  • 22. Staph. aureus peritonitis Staph. Aureus on culture D/c gram –ve coverage, cont. gram +ve coverage for 3 weeks If MRSA change to Vancomycin and rifampin can be added (600 mg/day for 1 week) If clinical improvement continue for 3 weeks If no clinical improvement reculture and revaluate for exit-site or tunnel Infection or intra-abd abscess If peritonitis with exit-site or tunnel Infection – remove catheter Allow 2 weeks rest period before reinitiating PD If no improvement in 5 days on appropriate antibiotics, remove catheter
  • 23. Enterococcus/Streptococcus peritonitis Enterococcus/Strep on culture D/c empiric coverage Start continuous Ampicillin 125 mg/L each bag Consider adding aminoglycoside for enterococcus If ampicillin resistant, start vanco; If VRE consider quinupristin/dalfopristin or linezolid Clinical improvement; treat for 2 weeks – strep 3 weeks - enterococcus No improvement, reculture and evaluate for exit-site or tunnel infection Peritonitis with exit or tunnel infection Consider catheter removal Treat for 3 weeks In no improvement by 5 days, remove catheter
  • 24. Pseudomonas peritonitis Pseudomonas on culture W/o exit-site/tunnel infection With exit-site/tunnel infection Remove catheter Use 2 abx with different mechanism Oral quinolone, cephalosporin, piperacillin based on sensitivities If clinical improvement Treat for 3 weeks If no improvement reculture and evaluate If no improvement by 5 days on appropriate abx, remove catheter
  • 25. Gram negative organism peritonitis Single gram –ve organism on culture E. coli, klebsiella or proteus Stenotrophomonas 3 rd generation cephalosporin: ceftazidime or cefepime Two drugs with different mechanisms based on sensitivity pattern Duration of therapy: 3 weeks Duration of therapy: 3-4 weeks If no clinical improvement by 5 days, remove catheter
  • 26. Polymicrobial peritonitis Polymicrobial peritonitis Multiple gram –ve organisms Multiple gram +ve organisms Change to metronidazole In conjunction with ampicillin, Ceftazidime or aminoglycoside Surgical evaluation Laprotomy for suspected intra-abd pathology/abscess with catheter removal Continue therapy based on sensitivities W/o catheter infection, treat for 3 weeks With catheter infection, remove catheter
  • 27. Culture negative peritonitis Culture negative peritonitis 24-48 hours Continue initial therapy If culture negative for 72 hours Repeat cell count and diff Infection resolving, pt improving Infection not resolving Cont initial therapy for 2 weeks, But D/c aminoglycoside if used initially Special culture techniques for Mycobacteria or legionella Culture positive Culture negative Adjust therapy as per sensitivity patterns If no improvement in 5 days, Consider catheter removal
  • 28.
  • 29. Antibiotic dosing recommendations for CAPD LD: loading dose in mg, MD: maintenance dose in mg Antibiotic Intermittent Continuous Gentamicin 0.6 mg/kg LD 8, MD 4 Amikacin 2 mg/kg LD 25, MD 12 Cefazolin 15 mg/kg LD 500, MD 125 Cefepime 1 gm LD 500, MD 125 Cephalothin 15 mg/kg LD 500, MD 125 Ceftazidime 1 – 1.5 gm LD 500, MD 125 Ciprofloxacin No data LD 50, MD 25 Vancomycin 15-30 mg/kg every 5-7 days LD 1000, MD 25 Aztreonam No data LD 1000, MD 250 Amphotericin NA 1.5 Imipenem/cilistatin 1 gm bid LD 500, MD 200
  • 30.
  • 31.
  • 32.
  • 33.
  • 34.
  • 35.
  • 36.
  • 37.
  • 38.  
  • 39. Treatment of exit-site/tunnel infection Purulent discharge from exit-site Do culture/gram stain Gram +ve organism Gram –ve organism 1 st generation Cephalosporin PO PO Quinolones If slow improvement or severe Cases add Rifampin 600mg/day If Pseudomonas and no improvement add 2 nd anti-pseudomonal; ceftazidime IP Infection resolving; cont treatment for 2 weeks Infection resolving; cont treatment for 2 weeks Infection unresolved in 3-4 weeks; consider catheter revision/removal Infection unresolved in 3-4 weeks; consider catheter revision/removal
  • 40.
  • 41.
  • 42.
  • 43.  
  • 44.
  • 45.
  • 46.
  • 47.
  • 48.
  • 49.
  • 50.
  • 51.
  • 52.
  • 53.  
  • 54.
  • 55.
  • 56.
  • 57.
  • 58.
  • 59.
  • 60.
  • 61.
  • 62.
  • 63.
  • 64.
  • 65.
  • 66.
  • 67.
  • 68.
  • 70.  
  • 71.
  • 72.
  • 73.
  • 74.
  • 75.
  • 76.  
  • 77.  
  • 78.